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Abstract 
Congenital microcoria (MCOR) is a rare autosomal dominant disorder characterized by inability 
of the iris to dilate owing to absence of dilator pupillae muscle. So far, a dozen MCOR families 
are reported worldwide. By using whole-genome oligonucleotide array CGH, we have identified 
deletions at 13q32.1 segregating with MCOR in six families originating from France, Japan and 
Mexico. Breakpoint sequence analyses showed nonrecurrent deletions in 5/6 families. The 
deletions varied from 35 Kbp to 80 Kbp in size, but invariably encompassed or interrupted only 
two genes: TGDS encoding the TDP-glucose 4,6-dehydratase and GPR180 encoding the G 
protein-coupled receptor 180, also known as intimal thickness-related receptor (ITR). Unlike 
TGDS which has no known function in muscle cells, GPR180 is involved in the regulation of 
smooth muscle cell growth. The identification of a null GPR180 mutation segregating over two 
generations with iridocorneal angle dysgenesis which can be regarded as a MCOR 
endophenotype is consistent with the view that deletions of this gene, with or without the loss 
of elements regulating the expression of neighboring genes, are the cause of MCOR.  
3 
 
Main text 
Inherited congenital microcoria (MCOR) [MIM156600], also referred to as congenital miosis, is a rare 
inborn error of iris development. It is characterized by a small pupil (diameter < 2 mm) that dilates 
poorly or not at all in response to topically administered mydriatic drugs. Dilation inability results from 
absent or incompletely developed dilator pupillae muscle. The sphincter pupillae muscle which acts in 
opposition to the dilator muscle to cause constriction of the pupil is unaltered. In addition to abnormal 
dilator pupillae muscle, the miotic iris is thin and it displays abnormal stroma and iridocorneal angle.
 1-4
 
Iris thinning is consistent with transillumination of miotic irises and high sensitivity to light. High myopia 
and glaucoma are frequently associated with this condition.
5-8 
 
MCOR is a bilateral disease transmitted as an autosomal dominant trait with complete penetrance. A 
unique 8 Mb locus on chromosome 13q31-q32 has been mapped in 1998 by linkage analysis
9 
in a 
large multigenerational French pedigree first described in 1964.
10
 Gene mapping in some other 
families confirmed linkage to this locus
11
 whereas some others were inconsistent with the 13q31-q32 
region, supporting genetic heterogeneity of the disease.
 12
 
Here, we report a study combining Sanger sequencing and array comparative genomic hybridization 
(CGH) which allowed the identification of the molecular defect underlying the disease at the 13q31-32 
locus. 
We obtained DNA samples of affected and unaffected members of six MCOR families originating from 
France, Japan and Mexico (FR1-2, JP1-2, MX1-2, respectively). Three out of these families were 
previously reported (FR1, the original family which allowed mapping of the MCOR locus on 
chromosome 13q31-q32,
9,10
 JP1
6  
and MX1
4
).
 
The pedigrees of the families are presented in Figure 1. 
The study was approved by Ethics committees of each participating Institutions, namely Paris Ile-de-
France II, University of Occupational and Environmental Health, Japan and Instituto de Oftalmologia 
Conde de Valenciana, Mexico City. Individuals participating to the study provided informed consents 
for molecular analyses. 
Sanger sequencing of the coding region and intron-exon boundaries of genes lying within the 8 Mb 
MCOR interval on 13q31-q32, and whole exome sequencing combined with linkage analysis failed to 
detect candidate disease-causing variants segregating with the disease in families FR1 and JP1, 
respectively (Table S1, Figure S1). Considering the strong linkage at the locus in FR1 (Zmax = 9.79,  
= 0),
9 
we assumed that the mutation in this family was present in an unscreened region or that it might 
consist in a genomic rearrangement undetectable using PCR-based screening methods. To assess 
this latter hypothesis, we subjected the DNA of an affected individual (FR1_III7, Figure 1) to 
comparative genomic hybridization (CGH) on high resolution oligonucleotide microarray (Affymetrix 
Cytogenetics Whole-Genome 2.7M Array). Calculation of test over reference Log2 intensity Ratios 
identified a 54.8 Kbp deletion in the 13q32.1 region (Figure 2, Figure S2). We amplified the junction 
fragment by subjecting the genomic DNA of the index case to PCR using primers designed just 
outside of the predicted deletion boundaries (Table S2, Figure S3). Direct sequencing of the 1.1 Kb 
intervening segment showed that the deletion extended from 95,227,374 to 95,277,864 (positions on 
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chromosome 13 according to the Genome Reference Consortium Human Build 37) with centromeric 
and telomeric breakpoints in intron 11 and intron 8 of the tail-to-tail genes: TDP-glucose 4,6-
dehydratase (TGDS, NM_014305.2) and the G protein-coupled receptor 180 (GPR180, 
[NM_180989.5], also known as intimal-thickness-related receptor, ITR [MIM607787]), respectively 
(Table 1 and Figure 2).  
Interestingly, multiplex PCR of short fluorescent fragments (QMPSF)
13
 using primer pairs specific to 
GPR180, TGDS and a control gene (CFTR, NM_000492.3, Table S3) suggested hemizygosity at 
13q32.1 in the other French family as well as the two Japanese and two Mexican MCOR families 
(Figure S4). In all five families, array CGH confirmed the presence of 13q32.1 deletions, which 
estimated sizes ranged from 39 Kbp to 88.9 Kbp (Figure S2). Direct sequencing of intervening 
segments amplified using primers designed just outside of the predicted breakpoints (Table S2) 
showed that the deletions extended from 95,241,606 to 95,276,905 (35.3 Kbp encompassing 4/12 
TGDS and 7/9 GPR180 exons), 95,228,262 to 95,300,908 (72.6 Kbp encompassing 11/12 TGDS 
exons, GPR180 and mir_562), 95,236,251 to 95,309,380 (73.1 Kbp encompassing 4/12 TGDS exons, 
GPR180 mir_562 and 5S_rRNA) and 95,225,217 to 95,305,083 (79.9 Kbp encompassing GPR180, 
mir_562 and 5S_rRNA) in families FR2, JP1, JP2 and MX1, respectively (Table 1, Figure 2). 
In family MX2, we failed to amplify the intervening segment using primers designed with array CGH 
data. Considering that MX1 and MX2 families had the same ethnic background and shared the same 
predicted distal deletion breakpoint (Table 1 and Figure S2) we assumed that both families could have 
inherited the same deletion by descent and that, in corollary, lack of amplification of the junction 
fragment in family MX2 could result from incorrectly predicted proximal deletion breakpoint. Using the 
primers designed to amplify family MX1 junction fragment, we were able to amplify family MX2 
intervening segment (Figure S3). Direct sequencing demonstrated the two families shared the exact 
same deletion (Table 1 and Figure 2). Analysis of microsatellite markers of chromosome 13q31-q32 
showed that the deletion was carried by a common 6.4 Mb haplotype suggesting that it might have 
been transmitted within both families by a common ancestor (Figure S5). 
Deletion fragment-specific PCR assays based on the amplification of intervening segments in all 
available DNA samples (see Figure 1) allowed us to confirm the co-segregation of the deletions with 
the disease in 4/6 families (Figure S3). Segregation analysis could not be performed in Families FR2 
and JP2 because of a lack of DNA samples. Positive PCR amplification of intragenic GPR180 
fragments confirmed heterozygosity of all deletions (not shown). 
The copy number variations identified in this study are publicly available in the DECIPHER database 
as 301464, 301465, 301468, 301469, 301471 and 301472. None of them have been previously 
reported in the DECIPHER database, the Database of Genomic Variants (DGV) or in the cohort of 
individuals affected with variable diseases analyzed by array CGH at our Institute (n = 96; unpublished 
data). However, chromosome 13q deletions are not uncommon and cause a wide spectrum of 
phenotypes correlated to the size and position of the deleted region. To our knowledge, microcoria 
has not been described in individuals with 13q deletions encompassing the 13q32.1 region. However, 
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microcoria could be overlooked or could not manifest owing to severe eye dysgenesis since about one 
third of children with 13q deletion syndrome have iris and choroid coloboma, glaucoma, cataracts, and 
cloudy lenses. Together, these data are consistent with the causality of 13q32.1 deletions in MCOR. 
Inspection of sequences surrounding MCOR deletion breakpoints identified a duplicated sequence 
prone to recurrent nonallelic homologous recombination (NAHR)
 
in a unique family (FR2, 37bp 
sequence shared between TGDS intron 4 and GPR180 intron 7 at positions 95,241,662-95,241,698 
and 95,276,905-95,276,998, respectively; Figure S6).  
Recently, several microhomology-mediated repair mechanisms have been described in the etiology of 
non-recurrent CNVs in human disease.
14-16
 These mechanisms, which are guided by the surrounding 
genomic architecture, include microhomology-mediated end-joining (MMEJ),
17
 fork stalling and 
template switching (FoSTeS),
18
 microhomology-mediated break-induced replication (MMBIR),
19
 serial 
replication slippage (SRS),
20
 and break-induced SRS (BISRS).
21 
 Extensive bioinformatic analysis of 
MCOR deletion breakpoints and surrounding genomic architecture allowed the identification of 
perfectly matching 1 or 2 base pairs shared between the proximal and distal sequence at the 
junctions, sequence motifs and/or repetitive elements which are likely to stimulate the formation of the 
13q32.1 deletions by increasing susceptibility of DNA breakage or promote replication fork stalling 
(Table S4, Figures S6-7). These findings are consistent with the view that microhomology-mediated 
mechanisms underlie non-recurrent MCOR deletions in families FR1, JP1, JP2, MX1 and MX2. 
The minimal common deletion disrupted GPR180 and TGDS (Table 1 and Figure 2), raising the 
possibility that haploinsufficiency of one or the two genes, or alternatively the loss of regulatory 
elements, might give rise to the phenotype. 
GPR180 encodes a 201 amino-acid G protein-coupled receptor
22
 of the Rhodopsin-like receptors 
family which includes hormones, neurotransmitters, and light receptors, all of which transduce 
extracellular signals upon interaction with guanine nucleotide-binding proteins and activating ligands.
23 
Very little is known about the function of GPR180. However, it has been reported to be produced 
predominantly in vascular smooth muscle cells where its expression is upregulated in response to 
experimental injury.
24
 The significant suppression of DNA synthesis and inability to produce neointima 
in response to vascular injury in the Gpr180-/- mouse suggest that
 
upregulation of Gpr180 signaling 
contributes to vascular smooth muscle growth.
22
 In addition, gene expression profiling in normal 
human tissues have shown that it is highly expressed in myoepithelia (salivary gland, 
endomyometrium, prostate, lung and liver).
25
 In the eye, GPR180 is less abundant than in 
myoepithelia. However, it is listed in the top 20 genes having a significantly higher expression in the 
iris compared to the other ocular structures.
26
 Hence, considering that the dilator pupillae arises during 
embryonic life by the differentiation of iris epithelial cells into myoepithelial cells,
27,28 
 GPR180 was 
regarded as a strong candidate MCOR gene. 
The Gpr180-/- mouse had resistance to experimental thickening of the intima but normal appearance, 
growth rate, reproduction, and histology of major organs.
22
 We examined Gpr180-/- and Gpr180+/- 
mice for anterior segment development and iris function. We found that both heterozygote and 
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homozygote Gpr180-null eyes were undistinguishable from adult age-matched controls (Figures S8-
S10). In particular, we found no iris transillumination and normal drug-mediated mydriasis both in 
heterozygote and homozygote Gpr180-null mice.However, inspection of our in house exome database 
(>4200 exomes) for GPR180 nonsense or frameshift variants with an acceptable amount of reads (≥ 
10) identified a unique heterozygote GPR180 nonsense mutation (c.343 C>T; p.Gln115*). This variant 
was found in our own series of individuals with neonatal retinal dystrophy, namely Leber congenital 
amaurosis (LCA, [MIM204000]). Interestingly, the ophthalmologic file of the blind individual harboring 
the p.Gln115* substitution (II2, family FR3; Figure 3) mentioned an abnormal iridocorneal angle at 
examination of the anterior segment of the eye. The individual, her parents and siblings consented to 
ophthalmological examination and genetic analysis. Iridocorneal angle dysgenesis was evidenced in 
all family members but the mother and a brother affected with LCA (family FR3; Figure 3). Evidence of 
father-to-son transmission demonstrated autosomal dominant transmission of the iridocorneal defect 
which segregated with the p.Gln115* substitution, independently from the autosomal recessive retinal 
disease (Figure 3). Whole-genome SNP genotyping data generated using Affymetrix GeneChip 
Human Mapping 10K 2.0 Arrays were available in this family. Retrospective analysis for linkage with 
the autosomal dominant anterior segment dysgenesis pointed 15 candidate chromosomal regions, 
including a region on 13q32.1 containing GPR180 (Figure S11). Retrospective analysis of exome data 
found no heterozygote loss-of-function variants in any of these regions other than the GRP180 
p.Gln115* substitution, supporting the role of GPR180 in the development of the irido-corneal angle. 
Nevertheless, none of the five individuals with both iridocorneal angle dysgenesis and the p.Gln115* 
substitution had abnormal pupillary response or iris transillumination. Considering that iridocorneal 
angle dysgenesis is a constant symptom in congenital microcoria linked to 13q32.1 (31/31, 5/5, 1/1, 
2/2 and 3/3 of examined MCOR individuals in families FR1
5,9
, JP1
6
, JP2, MX1 and MX2, respectively; 
Figures 1 and 3), goniodysgenesis in family FR3 may be regarded as a MCOR endophenotype. 
The reason why heterozygosity for the p.Gln115* substitution was not sufficient to cause the full range 
of MCOR symptoms could reside in the production of a truncated protein retaining some of its function. 
Alternatively, premature termination codon (PTC) self-correcting mechanisms could be involved, in 
particular translational read-through which has recently been reported to be more abundant than 
expected in higher species, including human.
29
 Nonsense-associated altered splicing (NAS), which 
consists in selective exclusion of an in-frame exon with a premature termination codon, is another 
possible correcting mechanism. 
30–33
 Recently, a nonsense mutation in CEP290 which mutations 
cause blindness has been shown to induce exon skipping and to lead to a relatively mild retinal 
phenotype.
34
 Because the skipping of GPR180 exon 2 would not disrupt the open reading frame, NAS 
could explain why the p.Gln115* substitution is not as detrimental as gene ablation. 
The p.Gln115* substitution was not reported in the Exome Aggregator database (ExAC), Exome 
Variant Server (EVS), 1000Genome and dbSNP datasets. However, we identified in the ExAC 
database twelve other rare variants which may cause protein truncation (6 nonsense and 6 frameshift 
mutations, 0.00004 <minor allele frequency <0.000008; Table S5). Provided that these variants are 
confirmed, studying their molecular consequence at the mRNA and/or the protein levels and, knowing 
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the ophthalmologic status of carrier individuals will certainly help in understanding the role of GPR180 
in MCOR and goniodysgenesis. Meanwhile, to address this important question, we screened the 
GPR180 exome for mutations in a series of individuals having an eye disease with goniodysgenesis, 
including ten individuals with Axenfeld-Rieger anomaly or Peters anomaly [MIM604229] and no PAX6, 
PITX2, FOXC1, CYP1B1, MAF or MYOC mutation (n = 5 and n = 5, respectively), and eleven index 
cases of primary congenital glaucoma (n = 9) or juvenile glaucoma (n = 2) with no CYP1B1 mutations. 
Primer sequences are given in Table S6. No GPR180 candidate disease variants were identified in 
GPR180 exon and intron-exon boundaries in any of the individuals.  
Despite strong arguments in favor of the involvement of GPR180 in MCOR, in the absence of 13q32.1 
deletions which do not disrupt TGDS, or of a GPR180 mutation that causes the full MCOR phenotype, 
we cannot formally exclude that haploinsufficiency of GPR180 is necessary, but not sufficient, for 
MCOR to manifest. 
The second gene lost or disrupted in MCOR individuals, TGDS, encodes the dTDP-D-glucose 4,6-
dehydratase, an evolutionarily conserved NAD-dependent sugar epimerase/dehydratase of the short 
chain dehydrogenase/reductase extended-type family (SDR2E1, EC:4.2.1.46). In human, SDR 
enzymes display a wide substrate spectrum, ranging from steroids, alcohols, sugars, and aromatic 
compounds to xenobiotics.
35
 TGDS catalyses the dehydration of dTDP-alpha-D-glucose into dTDP-4-
dehydro-6-deoxy-alpha-D-glucose. It contributes to deoxy-sugar metabolism,
35,36
 but its exact function 
is unknown. In bacteria, TGDS is essential to the biogenesis of cell envelope components and 
antibiotics,
37
 while in C. elegans, it is required for normal growth rates, larval development and 
survival, reproduction and coordinated locomotion.
38
 In human eyes, TGDS expression is lower than 
that of GPR180, and unlike this latter, it has no preferential expression in the iris
26
. More 
importantly,very recently, biallelic TGDS mutations have been reported to cause Catel-Manzke 
syndrome [MIM302380] which is characterized by Pierre Robin sequence (MIM 261800; HP:0000201) 
and a unique form of bilateral hyperphalangy causing clinodactyly of the index finger (HP:0009467).
39
 
Neither the affected individuals, nor their heterozygote parents are reported to have eye 
disease.
39
Therefore, it is unlikely that TGDS dysfunction in human is responsible for MCOR. 
Finally, it cannot be excluded that full range of MCOR symptoms are due to both the loss of GPR180 
function and to that of elements that regulate the expression of neighboring genes by position effect. 
Inspection of the ENCODE repository for transcription factor-binding site identified by CHIPseq 
detected no eye-specific binding sites in the 35.3 Kbp sequence of the shortest MCOR deletion 
(Figure S12). Likewise, inspection of the database of conserved non-coding orthologous regions 
(CONDOR) identified no highly conserved non-coding elements (HCNE) in the 35.3 Kbp MCOR 
minimal region. However, two genes involved in eye development are located close to the MCOR 
region, namely DCT [MIM191275] which encodes the dopachrome tautomerase and SOX21 
[MIM604974] which encodes SRY-related high-mobility-group box 21. 
DCT is located 110 Kbp upstream of proximal boundary of the minimal interval (Figure 2). It functions 
downstream of tyrosinase (TYR) [MIM606933] and tyrosinase-related protein-1 (TRP1) [MIM115501) 
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in the biosynthetic pathway of eumelanin in pigment cells. In the mouse, Dct mutations cause the Slaty 
phenotype in which the iris is normal in the first months of life. Later-on, age-related dispersed pigment 
across the surface of the iris combined with mild transillumination is noted
40
. To our knowledge, no 
DCT mutation is reported in human disease so far but 10 loss-of-function alleles are described in EVS. 
One of these variants, p.Tyr75Serfs*50 is homozygous in 12/6249 individuals, making unlikely a 
contribution of DCT loss-of-function in MCOR. However, considering that pigmentation has a role on 
the development of the neuroretina,
41,42
 it cannot be excluded that 13q32.1 deletions cause DTC 
overexpression and dysregulate iris development mechanisms. 
SOX21 is located 75 kbp upstream of the distal boundary of the minimal MCOR interval (Figure 2). 
Sox21 has been reported to be a general mediator of the effects of Sox2
43
 which interaction with Pax6 
is crucial to coordinate eye development
44
. It is known to be expressed in the developing lens in 
chicken
45
 and zebrafish.
46
 Additionally, sox21b knock-down in the zebrafish causes lens 
malformation.
47
 In the mouse, complete inactivation of Sox21 has been reported to cause cyclic 
alopecia,
48
 but the ocular phenotype of the animal is unknown. Altered regulation of SOX21 
expression in MCOR individuals cannot be excluded. 
In summary, here we report heterozygote 13q32.1 deletions in 6/6 MCOR families of variable ethnic 
origin, which invariably encompass GPR180 and TGDS. We suggest that GPR180 ablation, alone or 
in combination with the loss of elements that regulate the expression of neighboring genes by position 
effect, is the cause of the disease. Further studies will hopefully allow the identification of the 
molecular mechanisms underlying this rare disease. It should provide further insights into the 
development of the anterior chamber of the eye, which anomalies are an important cause of visual 
loss due to glaucoma. 
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Legends to tables and figures 
 
Table 1. Summary of 13q32.1 deletions identified by array CGH and characterized by 
sequencing of the intervening segments. †denotes a partial deletion of the gene (see Figure S2). 
Sequences shared between the proximal and distal sequences at the junction are underlined. The 
breakpoint (/) has been arbitrary placed at the 5’ of the identical se uences. Nucleotide positions refer 
to the human genome reference sequence (hg19 assembly) available at UCSC 
(http://genome.ucsc.edu/). 
 
Figure 1. Pedigrees of the six families segregating MCOR. Autosomal dominant transmission is 
supported by father to son transmission in all six families. Individual numbers in pedigrees FR1
9
 and 
JP1
6
 are those previously reported. Available DNAs can be identified by the presentation of their 
genotype at the 13q32.1 locus (Del: deletion, +: wildtype allele). Individuals affected with MCOR who 
were examined by gonioscopy (asterisk) had all iridocorneal angle dysgenesis.  
 
Figure 2. Overview of the 13q32.1 deletions identified in MCOR. Overview of the 13q32.1 locus 
(chr13:95,110,000-95,375,000; hg19) with custom tracks showing the delineated deletions presented 
in this study (horizontal red bars). At the top, the RefSeq Genes Track is included. In addition, 
ENCODE and conservation tracks are displayed. 
 
Figure 3. Pedigree, GPR180 genotypes and gonioscopic aspects in family FR3 and FR1. The iris 
spicules (arrows) consistent with an abnormal development of the iridocorneal angle are seen in 
individuals harboring the GPR180 c.343C>T (p.Gln115*) mutation only as well as in individual FR1_V1 
affected with microcoria. MCOR: microcoria; GD: goniodysgenesis; LCA: Leber congenital amaurosis.
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Deletions predicted by Array CGH Actual deletions 
 
 
Centromeric boundaries Telomeric boundaries  
  
  
Families Individuals 
+Probe 
(position) 
-Probe 
(position) 
-Probe 
(position) 
+Probe 
(position) 
Estimated 
size (Kbp) 
Deletion breakpoints 
Size 
(Kbp) 
Genes included or 
disrupted 
by the deletion 
Sequence of the junction fragment 
FR1 III7 
C-08UO9 
95,224,547 
C-08UOA 
95,225,723 
S-2NJCM 
95,276,735 
C-08UPK 
95,279 ,378 
54.8 
 
95,227,374-95,277,864 
50.5 TGDS†, GPR180† 
AAAAATCAACTATTTTTTTCTTCTTAACTTC
TAAAGTCATTCAATACTGAACTTGGT/ATGC
AAATATGAATGTACATTCTTTTTTCTTTTAC
AGGAATATTACACATTTGTG 
FR2 II1 
C-3ZRLF 
95,238,814 
C-3DRMS 
95,238,827 
C-6YHLK 
95,277,799 
C-4AEYA 
95,277,841 
39.0 95,241,606-95,276,905 35.2 TGDS†, GPR180† 
TCACCCAGGCTGGAGTGCAGTGGTGCAACCT
CAGCTCACTGCAAGCTCTGTCTCCC/GGGTT
CACGCCATTCTCCTGCCTCAGCCTCCCGAGT
AACTCGCGCCCACGCCCGGCTAAGTTTTTGT
ATTTTTAGTAGAGACGGGGTTTCACCG 
JP1 IV1 
S-4RUHL 
95,211,097 
C-7G8VT 
95,211,706 
C-5TEUV 
95,299,777 
C-5TIVX 
95,300,029 
88.9 
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72.6 TGDS†, GPR180, mir_562 
ATCATTATTTTACATACATGTAAAAAAGAAA
AAAGCTACAATAATAATTATAAGACACCAGT
/GTCCTCTCTCAGCACAGCAGTTTACTTCTT
CAGGGGCAGCAGGAGAATCTCTCTGACTTC 
JP2 III7 
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95,238,827 
S-4OHPW 
95,309,706 
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70.9 
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73.1 
TGDS†, GPR180, mir_562, 
5S_rRNA 
CGATGATCAATGTCACTTACAGTAAGAAAAA
CCCAAATTAAAAACTCAGAGATAC/TCTCAT
TCTCCAGCTGAAATTCTCAGAAATAATGTCT
ATGCCATGTACTTTCCCC 
MX1 II3 
S-3HRGB 
95,218,014 
C-6DQEK 
95,219,578 
C-6IBIF 
95,305,254 
C-4DJSK 
95,305,294 
87.2 
 
95,225,217-95,305,083 
 
79.9 
TGDS, GPR180, mir_562, 
5S_rRNA 
AACCAACTGAAAGGAGAAAAAAAGTTGATCT
TAGTTTATAGATGGATTGGCCTGTTC/TGAG
CCCCATAACAGTGAGCACCTCTAGCACCTAG
GATGCCAGCTGCATGTAT 
MX2 III1 
C-7ALKO 
95,227,834 
C-3GDLS 
95,227,835 
C-6IBIF 
95,305,254 
C-4DJSK 
95,305,294 
77.5 
 
95,225,217-95,305,083 
 
79.9 
TGDS, GPR180, mir_562, 
5S_rRNA 
AACCAACTGAAAGGAGAAAAAAAGTTGATCT
TAGTTTATAGATGGATTGGCCTGTTC/TGAG
CCCCATAACAGTGAGCACCTCTAGCACCTAG
GATGCCAGCTGCATGTAT 
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Figure S1. Multipoint parametric LOD scores in family JP1. Genome wide scan for mapping was 
performed using Illumina OminiExpress array (Illumina, Sandiego, CA, USA). All SNP markers were 
tested for Mendelian error prior to linkage analysis to exclude them from further analysis, and a set of 
markers were selected from the rest of the markers by the easyLINKAGE Plus program (v5.08). 
Multipoint parametric linkage analysis was performed by GeneHunter v2.1r5 program with an 
estimation of the disease allele frequency of 0.001 and a penetrance of 100% in a dominant model. 
Three candidate regions were compatible with linkage: chr9:1-85756778, chr13:47380943-60466889, 
and ch13:75085467-100692439. 
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Figure S2. Copy Number state on chromosome 13q32.1, determined by comparative genomic 
hybridization (CGH). Genomic DNAs (250 ng) were amplified, fragmented, labeled with biotin, and 
hybridized onto a Whole-Genome Cytogenetics 2.7M Array (individual FR1_III7) or CytoScan® HD 
Arrays (individuals FR2_II1, JP1_IV1, JP2_III7, MX1_II3, MX2_III1) as recommended by the 
manufacturer (Affymetrix, High Wycombe, United Kingdom). After scanning, the images of the chips 
(.dat files) were converted into .cel files using Command Console (version 3.2). The .cel files were 
analyzed for Copy Number variations and loss of heterozygosity (LOH) detection. The results obtained 
were visualized using Chromosome Analysis Suite version 2.0.0.195 with NetAffx Build 32.3 (hg19) 
annotations and reference files (Affymetrix). Array CGH analysis identifies five different heterozygote 
deletions invariably encompassing TGDS and GPR180. 
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Figure S3. PCR amplification of intervening segments and segregation analysis of 13q32.1 
deletions in MCOR families. The genomic DNA from affected and unaffected individuals were 
subjected to PCR amplification using primers designed just outside of the deletion breakpoints. The 
localization of the forward and reverse primers hampered amplification of the undeleted allele but not 
of the deleted allele, which size varied between 1.10 to 2.30 Kbp. L: 1 KbPlus DNA Ladder (Thermo 
Scientific). Positive and negative PCR amplifications in affected and unaffected individuals support 
cosegregation of the 13q32.1 deletions and the disease in 4/6 MCOR families (FR1, JP1, MX1 and 
MX2). All available samples of family FR1 (see Figure 1) were analyzed, but only a representative 
selection is shown. With respect to families FR2 and JP2, positive PCR amplifications are observed for 
individual II1 and III7 but no other DNAs were available. 
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Figure S4. Quantitative multiplex PCR of short fragments analysis to assess TGDS and GPR180 
copy numbers in MCOR individuals FR2_II1, JP1_IV1, JP2_III7, MX1_II3, MX2_III1. DNAs from 
affected and control individuals were subjected to a limited number of PCR cycles (n = 23) using dye-
labeled (6-FAM) primers specific to CFTR exon 25 (204 bp) and TGDS exon 2 (184 bp) or GPR180 
exon 2 (184 bp). Amplified fragments were separated by electrophoresis on an automated sequencer 
(Applied Biosystems, Foster City, CA). Data were analyzed using the Genescan software (Applied 
Biosystems) and the GeneScan-500 Rox as the ladder (Applied Biosystems). To determine TGDS and 
GPR180 copy numbers in affected individuals, the height of CFTR electrophoregrams were 
superimposed and adjusted to those generated from control DNAs and the heights of the 
corresponding peaks were then compared between the different samples. The 0.5 reduction of TGDS 
and GPR180 peak heights for individuals FR2_II1, JP1_IV1, JP2_III7, MX1_II3, MX2_III1 and 
FR1_III7 (deleted control) compared to FR1_V2 (undeleted control) support hemizygosity of exon 2 in 
both genes. 
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Figure S5. Haplotype analysis at the 13q31-q32 locus in the two MCOR Mexican families (MX1, 
MX2). Affected individuals of the two families share the same disease haplotype (in red) supporting 
founder effect. Chromosomal positions of microsatellite markers are indicated in base pairs according 
to the hg19 draft of the human genome sequence available at UCSC database. ?: clinical status 
unknown. 
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Proximal CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
FR1  CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
Distal TGTTCTAACCCTCAAACAGGTAACGACTATTAATGTTTTTTGTGTATTTT 
 
Proximal AAGTCATTCAATACTGAACTTGGTATAAATATTTAAGATTCTGATTTTAA 
FR1  AAGTCATTCAATACTGAACTTGGTATGCAAATATGAATGTACATTCTTTT 
Distal TACAGGATTTCTTTGTGTATCAGCATGCAAATATGAATGTACATTCTTTT 
 
Proximal GGAATTTGGGGTGTGGGAAATAAGTCATCTGCCCTGGTTTTAAGGTTATT 
FR1  TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Distal TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Proximal TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
FR2  TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
Distal  TCGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCACTGCAAGCTCCG 
 
Proximal TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAGTTGGGA 
FR2 TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
Distal  CCTTCCGGGTTCATGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
 
Proximal CTACAGGCGCCTGTCACCACGCCCGGCTAATTTTTTGTACTTTTAGTGGA 
FR2  CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Distal   CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Proximal ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
JP1  ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
Distal TACTGGCTGTCAGCCACGGCCACTCTTAGCATCTAGAGGCTGCTCCCAGT 
 
Proximal ACAATAATAATTATAAGACACCAGTGATTATAAAAATACATACCTTTTAG 
JP1  ACAATAATAATTATAAGACACCAGTGTCCTCTCTCAGCACAGCAGTTTAC 
Distal TCCTTGCTATGTGGCCCTCTCCCAGGTCCTCTCTCAGCACAGCAGTTTAC 
 
Proximal GAGTGTGAAGAAAGTGAAAAAATATGTACCTCAGAATAAATAATACAGGT 
JP1  TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Distal TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Proximal TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
JP2  TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
Distal CCAGTAGCTTGTGCTCACCGCAGGGAGGCTGGACTGGATGGTGACTGCAA 
 
Proximal ACCCAAATTAAAAACTCAGAGATACCACTTCTTACTTACCAGACTGGCAA 
JP2  ACCCAAATTAAAAACTCAGAGATACTCTCATTCTCCAGCTGAAATTCTCA 
Distal GATTTTGTTGTTCCTTGACAAATAATCTCATTCTCCAGCTGAAATTCTCA 
 
Proximal  AAATTCAAAAAGTTGACAAATCACTTAGTTGTTGAGGCTGTTAGGCAAAA 
JP2  GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Distal GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Proximal TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
MX1&MX2 TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
Distal AACTCTACACATAGTTTATTTTTAATATGTATACTTTCCTAGTGCCGTCC 
 
Proximal GTTTATAGATGGATTGGCCTGTTCTGTGGGTGCAAGCCAAAAATGGAGGG 
MX1&MX2 GTTTATAGATGGATTGGCCTGTTCTGAGCCCCATAACAGTGAGCACCTCT 
Distal ACTGCAAAAACCAAGAAACAATGGTGAGCCCCATAACAGTGAGCACCTCT 
 
Proximal TGGTTGCCTGAAAACCATGCAGGGGTGGCCTTAAAAAGAATGTGGAAAGA 
MX1&MX2 AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
Distal AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
Proximal CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
FR1  CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
Distal TGTTCTAACCCTCAAACAGGTAACGACTATTAATGTTTTTTGTGTATTTT 
 
Proximal AAGTCATTCAATACTGAACTTGGTATAAATATTTAAGATTCTGATTTTAA 
FR1  AAGTCATTCAATACTGAACTTGGTATGCAAATATGAATGTACATTCTTTT 
Distal TACAGGATTTCTTTGTGTATCAGCATGCAAATATGAATGTACATTCTTTT 
 
Proximal GGAATTTGGGGTGTGGGAAATAAGTCATCTGCCCTGGTTTTAAGGTTATT 
FR1  TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Distal TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Proximal TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
FR2  TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
Distal  TCGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCACTGCAAGCTCCG 
 
Proximal TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAGTTGGGA 
FR2 TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
Distal  CCTTCCGGGTTCATGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
 
Proximal CTACAGGCGCCTGTCACCACGCCCGGCTAATTTTTTGTACTTTTAGTGGA 
FR2  CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Distal   CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Proximal ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
JP1  ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
Distal TACTGGCTGTCAGCCACGGCCACTCTTAGCATCTAGAGGCTGCTCCCAGT 
 
Proximal ACAATAATAATTATAAGACACCAGTGATTATAAAAATACATACCTTTTAG 
JP1  ACAATAATAATTATAAGACACCAGTGTCCTCTCTCAGCACAGCAGTTTAC 
Distal TCCTTGCTATGTGGCCCTCTCCCAGGTCCTCTCTCAGCACAGCAGTTTAC 
 
Proximal GAGTGTGAAGAAAGTGAAAAAATATGTACCTCAGAATAAATAATACAGGT 
JP1  TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Distal TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Proximal TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
JP2  TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
Distal CCAGTAGCTTGTGCTCACCGCAGGGAGGCTGGACTGGATGGTGACTGCAA 
 
Proximal ACCCAAATTAAAAACTCAGAGATACCACTTCTTACTTACCAGACTGGCAA 
JP2  ACCCAAATTAAAAACTCAGAGATACTCTCATTCTCCAGCTGAAATTCTCA 
Distal GATTTTGTTGTTCCTTGACAAATAATCTCATTCTCCAGCTGAAATTCTCA 
 
Proximal  AAATTCAAAAAGTTGACAAATCACTTAGTTGTTGAGGCTGTTAGGCAAAA 
JP2  GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Distal GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Proximal TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
MX1&MX2 TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
Distal AACTCTACACATAGTTTATTTTTAATATGTATACTTTCCTAGTGCCGTCC 
 
Proximal GTTTATAGATGGATTGGCCTGTTCTGTGGGTGCAAGCCAAAAATGGAGGG 
MX1&MX2 GTTTATAGATGGATTGGCCTGTTCTGAGCCCCATAACAGTGAGCACCTCT 
Distal ACTGCAAAAACCAAGAAACAATGGTGAGCCCCATAACAGTGAGCACCTCT 
 
Proximal TGGTTGCCTGAAAACCATGCAGGGGTGGCCTTAAAAAGAATGTGGAAAGA 
MX1&MX2 AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
Distal AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
Proximal CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
FR1  CTAAAAAATTTATGATTAAAAATCAACTATTTTTTTCTTCTTAACTTCTA 
Distal TGTTCTAACCCTCAAACAGGTAACGACTATTAATGTTTTTTGTGTATTTT 
 
Proximal AAGTCATTCAATACTGAACTTGGTATAAATATTTAAGATTCTGATTTTAA 
FR1  AAGTCATTCAATACTGAACTTGGTATGCAAATATGAATGTACATTCTTTT 
Distal TACAGGATTTCTTTGTGTATCAGCATGCAAATATGAATGTACATTCTTTT 
 
Proximal GGAATTTGGGGTGTGGGAAATAAGTCATCTGCCCTGGTTTTAAGGTTATT 
FR1  TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Distal TTCTTTTACAGGAATATTACACATTTGTGCCTTGCTTTTGTCACTTAATA 
Proximal TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
FR2  TCACCCAGGCTGGAGTGCAGTGGTGCAACCTCAGCTCACTGCAAGCTCTG 
Distal  TCGCCCAGGCTGGAGTGCAGTGGCGTGATCTCGGCTCACTGCAAGCTCCG 
 
Proximal TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAGTTGGGA 
FR2 TCTCCCGGGTTCACGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
Distal  CCTTCCGGGTTCATGCCATTCTCCTGCCTCAGCCTCCCGAGTAACTCGCG 
 
Proximal CTACAGGCGCCTGTCACCACGCCCGGCTAATTTTTTGTACTTTTAGTGGA 
FR2  CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Distal   CCCACGCCCGGCTAAGTTTTTGTATTTTTAGTAGAGACGGGGTTTCACCG 
Proximal ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
JP1  ATGCCACTGATGGATCATTATTTTACATACATGTAAAAAAGAAAAAAGCT 
Distal TACTGGCTGTCAGCCACGGCCACTCTTAGCATCTAGAGGCTGCTCCCAGT 
 
Proximal ACAATAATAATTATAAGACACCAGTGATTATAAAAATACATACCTTTTAG 
JP1  ACAATAATAATTATAAGACACCAGTGTCCTCTCTCAGCACAGCAGTTTAC 
Distal TCCTTGCTATGTGGCCCTCTCCCAGGTCCTCTCTCAGCACAGCAGTTTAC 
 
Proximal GAGTGTGAAGAAAGTGAAAAAATATGTACCTCAGAATAAATAATACAGGT 
JP1  TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Distal TTCTTCAGGGGCAGCAGGAGAATCTCTCTGACTTCTAGAGTTTAGTTTAC 
Proximal TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
JP2  TAAATGGGTCCTTAAGATTACGATGATCAATGTCACTTACAGTAAGAAAA 
Distal CCAGTAGCTTGTGCTCACCGCAGGGAGGCTGGACTGGATGGTGACTGCAA 
 
Proximal ACCCAAATTAAAAACTCAGAGATACCACTTCTTACTTACCAGACTGGCAA 
JP2  ACCCAAATTAAAAACTCAGAGATACTCTCATTCTCCAGCTGAAATTCTCA 
Distal GATTTTGTTGTTCCTTGACAAATAATCTCATTCTCCAGCTGAAATTCTCA 
 
Proximal  AAATTCAAAAAGTTGACAAATCACTTAGTTGTTGAGGCTGTTAGGCAAAA 
JP2  GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Distal GAAATAATGTCTATGCCATGTACTTTCCCCCATATGTGACTGCATTAATT 
Proximal TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
MX1&MX2 TATAGAGGGTCCCATACAACCAACTGAAAGGAGAAAAAAAGTTGATCTTA 
Distal AACTCTACACATAGTTTATTTTTAATATGTATACTTTCCTAGTGCCGTCC 
 
Proximal GTTTATAGATGGATTGGCCTGTTCTGTGGGTGCAAGCCAAAAATGGAGGG 
MX1&MX2 GTTTATAGATGGATTGGCCTGTTCTGAGCCCCATAACAGTGAGCACCTCT 
Distal ACTGCAAAAACCAAGAAACAATGGTGAGCCCCATAACAGTGAGCACCTCT 
 
Proximal TGGTTGCCTGAAAACCATGCAGGGGTGGCCTTAAAAAGAATGTGGAAAGA 
MX1&MX2 AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
Distal AGCACCTAGGATGCCAGCTGCATGTATCACAGGTTTGGAGCAGGAAATTT 
 
 
Figure S6. Multiple sequence alignment of the 13q32.1 deletion junctions. Sequences of 150 bp 
surrounding each junction are aligned to the proximal (displayed in blue) and distal (displayed in 
green) reference sequences using Clustal Omega. The junction sequences are depicted in the color of 
the reference sequence they align with. Pink sequences depict microhomology and homology 
between the proximal and distal reference sequence and the junction in families FR1, JP1, JP2, MX1, 
MX2, and FR2, respectively. 
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Figure S7. Schematic representations of the genomic architecture for the 13q32.1 deletions. 
The breakpoint regions joined by the deletion are shown. A breakpoint region is displayed as the 
combination of two colored, solid lines together representing a 150 bp DNA sequence. The proximal 
breakpoint region consists of a non-deleted blue line and a deleted red line while the distal breakpoint 
region consists of a deleted red line and a non-deleted green line. Each deletion is composed of the 
two red, solid lines joined by the red dashed line which represents the different size of the deletion for 
every patient. The actual size of the deletions is indicated above the red dotted lines. The pink vertical 
arrows mark the position of the breakpoints displaying the number of base pairs of microhomology 
between both breakpoint regions and the junction product. The presence of repetitive elements is 
shown as bars of different shades of gray. Sequence motifs are indicated with orange, skewed lines 
intersecting with the sequence. Direct repeats are represented by dark purple arrows. 
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Figure S8. Iris phenotype of the Gpr180-null mice compared to heterozygote and wildtype 
animals. (A) The pupil diameter was invariably of 0.5 mm in the Gpr180 -/-, Gpr180 +/- and wildtype 
mice (n = 5 for each group). (B) Mydriasis upon 10 min treatment with neosinephrin 10% was highly 
variable in all animal groups (pupillary diameter ranging from 0.75 to 1.1 mm). (C) Gonioscopy reveals 
no difference in the iridocorneal line (arrow heads) between Gpr180 -/-, Gpr180 +/- and wildtype mice.  
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Figure S9. Routine histopathological evaluation of Gpr180-null mice iris. After enucleation, eye 
globes were immediately fixed in 10% buffered formalin before being automatically processed and 
embedded in paraffin. Four-micrometer paraffin-embedded sections were dewaxed in toluene and 
rehydrated through acetone bath to deionized water. Routine light microscopy evaluation was 
performed after haematoxylin and eosin staining (A-C) or Masson trichroma staining of sections 
bleached for melanin of uveal pigments, using hydrogen peroxide (H2O2) in phosphate saline buffer 
0.05M, pH 7.4, at 55°C for 50 minutes (D). Anterior uveal structures (iris, ciliary body (CB) and 
iridocorneal angle (ICA) of Gpr180-null mice were morphologically similar to wildtype and heterozygote 
animals. Iris constrictor muscle () was prominent while iris dilator was not possible to identify in any of 
the animals.  
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Figure S10. Alpha-smooth muscle actin (SMA) immunostaining of wildtype, gpr180+/- and 
grp180-null mice. Four-micrometer dewaxed sections of wildtype (A-B), Gpr180+/- (C-D) and 
Grp180-/- (E-F) mice were incubated with mouse monoclonal anti-monoclonal SMA antibody (1:25, 
M0635, Dako) for 25 min at room temperature and using ARK kit (Dako K3954) according to 
manufacturer’s recommendations. After washes, sections were then incubated with Alexa 488 
conjugated goat anti-mouse IgG (1:100 in PBT (PBS + 0.15% BSA + 0.1% Tween 20), Molecular 
Probes, Eugene, OR, USA) for 30 minutes at 37°C in a humid chamber. Fluorescent anti-alpha SMA 
immunohistochemistry allowed to clearly identify iris constrictor muscle (), outlined vascular arterial 
structures in iris stroma (), and few thin muscular fibers in ciliary body. The iris dilator appears as a 
discontinuous discrete staining at the base of the posterior bilayered iris epithelium (arrow head), in 
wildtype, Grp180+/- and Gpr180-null mice. 
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13q32.1
Maximum Lod-Score
 
Figure S11. Full parametric linkage analysis of family FR3 using a combination of Affymetrix 
GeneChip Human Mapping 10K 2.0 Arrays. Parametric LOD scores were calculated with the 
MERLIN software program. Arrows point regions where the LOD scores reach the maximum value 
which can obtained in the family (red line). The red arrow points the MCOR region on chromosome 
13q32.1. 
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Figure S12. Overview of transcription factor binding sites lying within the minimal 13q32.1 
MCOR deletion (chr13:95,241,606-95,276,905; hg19). The RefSeq Genes Track is displayed at the 
top and the Transcription factors CHIP-seq from ENCODE is shown at the bottom. 
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 JP1_III6 JP1_III7 
JP1_III6 
X 
JP1_III7 
Coverage 185X 184X - 
Total variants (>5 of depth and >0.2 of fraction) 142,152 145,070 92,834 
Variants with frequency < 1% or unknown in dbSNP135 13,196 15,122 5,428 
Heterozygote variants 9,644 10,826 3,603 
Acceptor/donor splice site, nonsense, indel, missense variants  484 556 228 
Acceptor/donor splice site, nonsense, indel, possibly/probably damaging
a
 229 260 80 
Variants mapping inside a candidate region (Figure 1S) 3 5 3b 
a. Predictions according to Polyphen2 
b. TUSC1_chr9:25678195-25678195 +CGC (exon1:c.124_125insGCG, p.S42delinsSG; NM_001004125); HRCT1_chr9:35906598-35906600 -ACC (exon1:c.314_316delACC: p.105_106del; 
NM_001039792.1); and UNC13B_chr9:35403470-35403470 C>T (p.A1455V; NM_006377.3) 
 
Table S1. Whole exome sequencing results in family JP1. JP1_III6 and JP1_III7 exomes were 
captured from genomic DNA (1 g) with in-solution enrichment methodology using the company's 
biotinylated oligonucleotide probe library (SureSelect Human All Exon 50 Mb Kits Version 3, Agilent, 
Santa Clara, CA, USA). Each genomic DNA was then sequenced on a sequencer as paired-end 100 
bases (Illumina HISEQ2000, Illumina, San Diego, USA). Sequences were aligned to the human 
genome reference sequence (hg19 assembly). The coverage was calculated as total reads/total 
genomic lengths. SNPs were called on the basis of the allele calls and read depth using the SAMtools 
(http://samtools.sourceforge.net/). Genetic variation annotation was performed by the ANNOVAR 
(http://www.openbioinformatics.org/annovar/). Considering that MCOR is rare dominant disease, we 
assumed that affected individuals were likely heterozygote for variants absent or <1% minor allele 
frequency in the dbSNP135. Consensus splice site changes, insertion/deletion and nonsynonymous 
variants (nonsenses, and probably/possibly damaging missense variants as predicted by Polyphen2) 
shared by the two affected individuals were selected. Inspection for variants in the candidate regions 
pointed by linkage analysis (Figure S1), detected one indel, one in-frame deletion and one missense 
change in the chr9:1-85756778 interval: TUSC1 [MIM610529], HRCT1 (NM_001039792.1) and 
UNC13B [MIM605836], code for a tumor suppressor candidate, histidine rich carboxyl terminus 1, and 
a protein important for synaptic vesicle exocytosis, respectively. Corresponding amino acids, p.S42 in 
TUSC1 and p.H105 in HRCT1 are located in single amino acid repetitive sequences, suggesting 
length polymorphisms. Variants in these genes are unlikely to cause MCOR.  
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Family Centromeric primer (5’-3’) Telomeric primer (5’-3’) Size (bp) 
FR1 tcccaaagattgaggcattc aaacttcaaatttatctgcttattgg 1098 
FR2 cagcaagtgttggcaagcat aaacttcaaatttatctgcttattgg 2297 
JP1 tgctagctaagtcttgccca aagtgaagggatcgtgcaga 1271 
JP2 tgtgtccctctagagaaccctaa gccctcacgtagcttttgat 1797 
MX1, MX2 ggagaatcatgcctttggaa ggcactgatgttgaatgcgt  1304 
 
Table S2. Sequences of primer pairs used to amplify the intervening segments in MCOR 
affected individuals harboring 13q32.1 intersticial deletions. The sizes of intervening segments 
are given. 
 
Gene Exon Forward primers (5’-3’) Reverse primers (5’-3’) Size (pb) 
TGDS 2 6FAM_tgattgtctctttagtggaaga gagcctctgaattgctaaaatga 184 
GPR180 2 6FAM_caggaatggctaaagctacagc tgggattatgctgtcaggaa 184 
CFTR 25 6FAM_gcttgagtgtttttaactctgtgg gggttcatcaagcagcaaga 204 
 
Table S3. Primer sequences and sizes of TGDS, GPR180 and CFTR amplicons used for QMPSF 
analysis. The forward primers have been labeled using the 6FAM fluorophore to allow analysis on an 
automated ABI3130 sequencer. 
15 
 
    
Proximal breakpoint region Distal breakpoint region  
 
Patient code Chromosomal position (hg19) 
Size 
(kb) 
Micro-
homology 
(bp) 
Repetitive 
element 
Number of 
sequence 
motifs 
Number of non-B 
DNA conformation 
prediction motifsa 
Repetitive 
element 
Number of 
sequence 
motifs 
Number of non-B 
DNA conformation 
prediction motifsa 
Sequence identity 
between repetitive 
elements 
Potential molecular 
mechanism 
FR1 chr13:95,227,374-95,277,864 50.5 2 - 8 - L1MC4a 3 1 - FoSTeS/MMBIR/NHEJ 
FR2 chr13:95,241,661-95,276,905 35.2 37 AluY 9 - AluY 9 - 83% 
NAHR/FoSTeS/MMBIR/
MMEJ 
JP1 chr13:95,228,262-95,300,908 72.6 1 MER104 10 - MLT1E1A 3 - - FoSTeS/MMBIR/NHEJ 
JP2 chr13:95,236,251-95,309,380 73.1 - L1MC5 5 - Tigger4 7 - - FoSTeS/MMBIR/NHEJ 
MX1 & MX2 chr13:95,225,217-95,305,083 79.9 2 ERV3-16A3_I-int 7 - L1MC5 12 - - FoSTeS/MMBIR/NHEJ 
a. Non-B DNA conformations should be located at both sides of the junction or overlapping the junction 
Table S4. Overview of bioinformatic analysis results for the MCOR deletion breakpoints and surrounding genomic architecture. 
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Chromosome:position_ 
variant 
Protein consequence Allele 
Count 
Allele 
Number 
Number of 
Homozygotes 
Allele 
Frequency 
13:95254225_G/A  p.Trp15Ter 1  11290  0  0.00008857  
13:95254299_C/T  p.Gln40Ter 1  17616  0  0.00005677  
13:95271542_T/A  p.Leu215Ter 2  122854  0  0.00001628  
13:95271735_G/T  p.Gly234Ter 1  122540  0  0.000008161  
13:95278239_T/A  p.Leu369Ter 1  122674  0  0.000008152  
13:95278286_C/T  p.Gln385Ter 3  122444  0  0.00002450  
13:95271434_T/TA  p.Val180SerfsTer18 1  122770  0  0.000008145  
13:95273380_T/TATGC  p.Gly265HisfsTer45 1  122930  0  0.000008135  
13:95273411_GA/G  p.Lys273SerfsTer24 5  122932  1  0.00004067  
13:95275395_T/TA  p.Ile310AsnfsTer5 3  122712  0  0.00002445  
13:95275491_C/CT  p.Tyr342LeufsTer41 1  122908  0  0.000008136  
13:95279324_CTCTT/C  p.Phe409CysfsTer15 1  122876  0  0.000008138  
 
Table S5: Rare GPR180 variants predicted to truncate the protein. Inspection of ExAC, EVS, 
1000Genome and dbSNP datasets pointed 12 nonsense and frameshift variants in the ExAC 
database, including one homozygote change, which reality needs to be demonstrated by Sanger 
sequencing. 
 
Exon Forward primer (5’-3’) Reverse primer (5’-3’) 
1 ggcctctgactggtgaatgt aggtgaggctggggaagt 
2 ttgcttctgaatgttgtgttca tgggattatgctgtcaggaa 
3 cacaaggtcttggatttctgag ggaaacacaggttgctttca 
4 ccccaaggtacaaaattgtttaag gcaagcataattttggtggact 
5 tcaaaaccactaaaactgtgttca tcctgttctcagtcaagctgat 
6 tttgaaaatggctttttgtgg tgacacaaattgtagaagctcaga 
7 aaaattcattttgtctagcttaggg tcccaaagaaaccagaacca 
8 ggcctgttgaggttaatcaga aaacttcaaatttatctgcttattgg 
9 tccttaaacaattagagttctgagca atgctctgctttcgctgttc 
 
Table S6. Primer pairs used to screen the GPR180 gene for mutations in individuals with 
goniodysgenesis. 
 
